| 1 |
26222195 | A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2. | 2015 Aug 27 |
1 |
| 2 |
21480221 | Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study. | 2012 Mar 1 |
2 |
| 3 |
14648207 | Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. | 2004 Feb |
1 |
| 4 |
15279827 | Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline. | 2004 Aug 8 |
1 |
| 5 |
12030840 | Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice. | 2002 May 15 |
1 |
| 6 |
11054538 | A cytochrome P4501B gene from a fish, Pleuronectes platessa. | 2000 Oct 3 |
1 |
| 7 |
9617978 | Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo. | 1998 Jun |
1 |
| 8 |
9512925 | Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes. | 1997 Oct-Dec |
1 |
| 9 |
2911085 | Selective mutagenic activation by cytochrome P3-450 of carcinogenic arylamines found in foods. | 1989 Feb 1 |
1 |